DOI: 10.3390/applmicrobiol3030043 ISSN: 2673-8007

β-Lactams and Ureas as Cross Inhibitors of Prokaryotic Systems

Monika I. Konaklieva, Balbina J. Plotkin
  • General Earth and Planetary Sciences
  • General Environmental Science

β-Lactams in the last thirty years have been viewed as universal acylating agents of serine and cysteine enzymes of both prokaryotic and eukaryotic systems. More recently, their use has been propelled by the COVID-19 pandemic, thus broadening their application as inhibitors of viral enzymes. The urea-based drugs have been extensively studied as inhibitors of the aforementioned enzymes. The focus of this review is the last decade’s drug discovery strategies, as well as new strategies that show utility in the expansion of β-lactams and ureas in the development of new antimicrobial and antiviral drugs.

More from our Archive